Please login to the form below

Not currently logged in
Email:
Password:

personalised treatments

This page shows the latest personalised treatments news and features for those working in and with pharma, biotech and healthcare.

Immuno-oncology, personalised medicine continues to drive pharma sector

Immuno-oncology, personalised medicine continues to drive pharma sector

Despite being the top trends affecting the industry this year, there has been a lot of scepticism surrounding the accessibility of novel I-O therapies and personalised treatments. ... Personalised medicines have been identified as key treatments by the

Latest news

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Delivering the promise of regenerative medicine Delivering the promise of regenerative medicine

    Once only imaginable in science fiction, the latest applications include engineered skin tissue to treat burns victims, custom-grown bones for implants and joint replacements, personalised dietary treatments using gut bacteria ... Regenerative medicine

  • Cannes Lions Healthcare Agency of the Year – championing change and demanding more… Cannes Lions Healthcare Agency of the Year – championing change and demanding more…

    AI and machine learning are revolutionising how we understand and use that data, helping us to develop new, more personalised treatments more quickly and more cheaply than we ever thought possible. ... But the reality of the best and most advanced

  • Reactivating drug research programmes Reactivating drug research programmes

    The actual number of drug trials that are abandoned each year before treatments reach the marketplace is unknown, at least at a global level. ... However, as drugs like Herceptin have shown, as long as there is a high degree of efficacy in a small group

  • Winning the war against cancer Winning the war against cancer

    Dr Josep Figueras on survival, access to treatments and the need for good data in oncology. ... The next five years are expected to see a wave of new oncology medicines that will address significant unmet medical needs, with personalised treatments being

  • Another lost decade for research? Another lost decade for research?

    We are emerging from a decade of intensive research into rare disease treatments. ... Such technologies, which allow doctors to diagnose bacterial from viral infections or distinguish between different bacteria, could lead to personalised treatments and

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest appointments

  • Horizon adds AZ’s Galbraith to board Horizon adds AZ’s Galbraith to board

    Galbraith is senior VP and head of oncology innovative medicines at AZ and knows Horizon well thanks to a collaboration between the two companies on personalised cancer treatments.

  • Horizon appoints board chair Horizon appoints board chair

    These growth prospects include a partnership with AstraZeneca to research personalised treatments in oncology.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

CHECKLIST 04: Let’s make your patient recruitment strategies a success
From how to generate insights to define your audience to drilling down those all-important key messages, our checklist has everything you need to think of, covered....
Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...

Infographics